Literature DB >> 25944351

Circulating cytokines and chemokines associated with plasma leakage and hepatic dysfunction in Brazilian children with dengue fever.

Ralph Antonio Xavier Ferreira1, Solange Artimos de Oliveira1, Mariana Gandini2, Laura da Cunha Ferreira1, Gladys Correa2, Fernanda Mattos Abiraude2, Mariana Mancebo Reid3, Oswaldo Gonçalves Cruz4, Claire Fernandes Kubelka5.   

Abstract

Dengue fever is usually a benign acute viral infection transmitted by arthropods but may evolve to severe clinical manifestations such as coagulation and/or hemodynamic disorders, caused mainly by an increase of vascular permeability. Deregulated circulating immunological factors have been associated with severity. In Brazil severe cases appeared in children only recently and we evaluated the profile of cytokine/chemokine kinetics in 134 hospitalized young patients during the epidemic in Rio de Janeiro in 2008. Inflammatory cytokines TNF and IFNγ were found elevated during the acute phase in children as well as the anti-inflammatory IL10 and chemokines MIF and CXCL10/IP10, all last three persisting longer during the recovery phase. Severe disease fitting the dengue hemorrhagic fever pattern (WHO, 1997) was associated with higher IL10 and CXCL10/IP10 circulating levels (peak levels at seven days with P<0.01 and P<0.001 respectively as compared to DF). These factors were higher in patients pulmonary effusion or ascites (P<0.05 for IL10 and P<0.01 for CXCL10/IP10). Both factors were also associated with liver changes such as AST increase correlated with CXCL10/IP10 (r=0.4300 with P<0.0001) and patients presenting painful hepatomegaly showed higher circulating levels of IL10 (P<0.01, at 7-9 days) and of CXCL10/IP10 (P<0.05, 4-6 days and P<0.001, 7-9 days) when compared to patients without apparent liver alterations. Most cases presented a history of prior infection (93%). This is the first study demonstrating cytokine and chemokine association with severity during dengue fever in Brazilian children. IL10 and CXCL10/IP10 play a role in the disease severity associated with induction of vascular leakage and a novel association with changes in liver dysfunction.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Brazil; Chemokines; Children; Cytokines; Dengue; Liver

Mesh:

Substances:

Year:  2015        PMID: 25944351     DOI: 10.1016/j.actatropica.2015.04.023

Source DB:  PubMed          Journal:  Acta Trop        ISSN: 0001-706X            Impact factor:   3.112


  29 in total

Review 1.  Immune-mediated cytokine storm and its role in severe dengue.

Authors:  Anon Srikiatkhachorn; Anuja Mathew; Alan L Rothman
Journal:  Semin Immunopathol       Date:  2017-04-11       Impact factor: 9.623

Review 2.  Host-Directed Antiviral Therapy.

Authors:  Naveen Kumar; Shalini Sharma; Ram Kumar; Bhupendra N Tripathi; Sanjay Barua; Hinh Ly; Barry T Rouse
Journal:  Clin Microbiol Rev       Date:  2020-05-13       Impact factor: 26.132

3.  18F-FDG as an inflammation biomarker for imaging dengue virus infection and treatment response.

Authors:  Ann-Marie Chacko; Satoru Watanabe; Keira J Herr; Shirin Kalimuddin; Jing Yang Tham; Joanne Ong; Marie Reolo; Raymond Mf Serrano; Yin Bun Cheung; Jenny Gh Low; Subhash G Vasudevan
Journal:  JCI Insight       Date:  2017-05-04

4.  Dengue virus-elicited tryptase induces endothelial permeability and shock.

Authors:  Abhay Ps Rathore; Chinmay Kumar Mantri; Siti Ab Aman; Ayesa Syenina; Justin Ooi; Cyril J Jagaraj; Chi Ching Goh; Hasitha Tissera; Annelies Wilder-Smith; Lai Guan Ng; Duane J Gubler; Ashley L St John
Journal:  J Clin Invest       Date:  2019-07-02       Impact factor: 14.808

Review 5.  The Good, the Bad, and the Shocking: The Multiple Roles of Dengue Virus Nonstructural Protein 1 in Protection and Pathogenesis.

Authors:  Dustin R Glasner; Henry Puerta-Guardo; P Robert Beatty; Eva Harris
Journal:  Annu Rev Virol       Date:  2018-07-25       Impact factor: 10.431

6.  Patterns and causes of liver involvement in acute dengue infection.

Authors:  Samitha Fernando; Ananda Wijewickrama; Laksiri Gomes; Chameera T Punchihewa; S D P Madusanka; Harsha Dissanayake; Chandima Jeewandara; Hemantha Peiris; Graham S Ogg; Gathsaurie Neelika Malavige
Journal:  BMC Infect Dis       Date:  2016-07-08       Impact factor: 3.090

7.  Meta-analysis of biomarkers for severe dengue infections.

Authors:  Kuan-Meng Soo; Bahariah Khalid; Siew-Mooi Ching; Chau Ling Tham; Rusliza Basir; Hui-Yee Chee
Journal:  PeerJ       Date:  2017-09-15       Impact factor: 2.984

8.  Primary dengue virus infections induce differential cytokine production in Mexican patients.

Authors:  Sergio Isaac de la Cruz Hernández; Henry Nelson Puerta-Guardo; Hilario Flores Aguilar; Silvia González Mateos; Irma López Martinez; Vianney Ortiz-Navarrete; Juan E Ludert; Rosa María del Angel
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-03       Impact factor: 2.743

9.  Cytokine Profile of Children Hospitalized with Virologically-Confirmed Dengue during Two Phase III Vaccine Efficacy Trials.

Authors:  Anke Harenberg; Aymeric de Montfort; Frédérique Jantet-Blaudez; Matthew Bonaparte; Florence Boudet; Melanie Saville; Nicholas Jackson; Bruno Guy
Journal:  PLoS Negl Trop Dis       Date:  2016-07-26

10.  Primary dengue haemorrhagic fever in patients from northeast of Brazil is associated with high levels of interferon-β during acute phase.

Authors:  Renato Antônio Dos Santos Oliveira; Mayara Marques Carneiro da Silva; Carlos Eduardo Calzavara-Silva; Ana Maria Silva; Marli Tenório Cordeiro; Patrícia Muniz Mendes Freire de Moura; Paulo Neves Baptista; Ernesto Torres de Azevedo Marques; Laura Helena Vega Gonzales Gil
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-05-24       Impact factor: 2.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.